| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc. (SUPN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. SUPN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 119.6K | $5.34M | - | |
| Dir | 61.3K | $2.74M | - | |
| Dir | 38.2K | $1.70M | - | |
| VP | 15.5K | $691.9K | - | |
| VP | 14.5K | $647.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2015 | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 1,950 | $19.23 | $37,498.50 | -69.8% | |
| Jun 17, 2015 | Sandell Scott D55 | 10% Owner | Sell | 136,597 | $16.50 | $2,254,420.43 | -73.7% | |
| Jun 17, 2015 | Baskett Forest53 | 10% Owner | Sell | 111,881 | $16.39 | $1,833,603.34 | -69.6% | |
| Jun 17, 2015 | Barris Peter J | 10% Owner | Sell | 111,881 | $16.39 | $1,833,603.34 | -69.6% | |
| Jun 17, 2015 | Barrett M James | Director, 10% Owner | Sell | 111,881 | $16.39 | $1,833,603.34 | -69.6% | |
| Jun 16, 2015 | Barris Peter J | 10% Owner | Sell | 55,105 | $16.85 | $928,668.03 | -33.0% | |
| Jun 16, 2015 | Baskett Forest53 | 10% Owner | Sell | 111,464 | $16.85 | $1,878,080.48 | -49.9% | |
| Jun 16, 2015 | Sandell Scott D55 | 10% Owner | Sell | 95,437 | $16.92 | $1,614,570.16 | -41.1% | |
| Jun 16, 2015 | Barrett M James | Director, 10% Owner | Sell | 55,105 | $16.85 | $928,668.03 | -33.0% | |
| Jun 12, 2015 | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 2,051 | $18.27 | $37,471.77 | -42.3% |